货号 | PRD7734-50 |
简介 | Supplied as ready-to-use 5 ug protein balls |
别名 | CDF; D factor; DIA; differentiation inhibitory activity; differentiation stimulating factor; Differentiation-stimulating factor; Emfilermin; HILDAcholinergic differentiation factor; leukemia inhibitory factor (cholinergic differentiation factor); leukemia inhibitory factor; Melanoma-derived LPL inhibitor; MLPLI | 全称 | Leukemia Inhibitory Factor |
反应种属 | Human |
来源 | E. coli-derived Pro24 - Phe202 |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 3976 (Human); 16878 (Mouse); 403449 (Canine) |
内毒素水平 | <0.01 EU per 1 μg of the protein by the LAL method. |
生物活性 | Measured in a cell proliferation assay using TF‑1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. |
背景 | Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. The activities of LIF are mediated through a high-affinity heterodimeric receptor complex consisting of two membrane glycoproteins: an alpha subunit (LIF R alpha, also known as LIF R beta and CD118) that binds LIF with low affinity and the 130 kDa (gp130) subunit that does not bind LIF by itself, but is required for high-affinity binding of LIF by the complex. |
Accession # | P15018 |
运输条件 | Blue Ice |
N-terminal Sequence Analysis | Pro24 |
预期分子量 | 19.6 kDa |
SDS-PAGE | 19 kDa, reducing conditions. |
存放说明 | 4℃ |
参考文献 |
|
1 μg/lane of ProDots® Recombinant Human LIF was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized with silver staining, showing a single band at 19 kDa and 17 kDa, respectively. | |
ProDots® Recombinant Human LIF demostrates cellproliferation activity in the TF-1 human erythroleukemic cell line.The ED50 for this effect is typically 0.02-0.12 ng/mL. |